-
Ciprofloxacin (hydrochloride) in Cell Assays
2026-09-24
Practical guidance for interpreting cell viability and cytotoxicity results when using Ciprofloxacin (hydrochloride), SKU C5539, as an experimental compound. The article covers bacterial targets, solvent compatibility, solution handling, literature limits, and evidence-based product selection.
-
High-Throughput Measurement of Drug-Induced Fractional Killi
2026-09-24
Inde, Rodencal, and Dixon describe an imaging-based protocol for tracking live and dead cells over time to quantify drug-induced fractional killing across many experimental conditions. Its central practical contribution is a scalable way to distinguish population-level cell loss from heterogeneous responses, demonstrated with inhibitors of the MAPK pathway.
-
Pepstatin A as a Causal Probe in I/R Endothelium
2026-09-23
Pepstatin A is an aspartic protease inhibitor that can help test whether cathepsin D activity is required for endothelial protection during ischemia/reperfusion. This article translates a recent cathepsin D study into a rigorous assay strategy, emphasizing causal interpretation, controls, and the limits of cross-model conclusions.
-
D-N-Acetylgalactosamine: Practical Protocol Guide
2026-09-23
D-N-Acetylgalactosamine (SKU B7904) provides a defined, water-soluble reagent for workflows examining glycoproteins, brain heteropolysaccharides, and related glycosylation measurements. It is appropriate for aqueous or compatible DMSO preparations, but should not be selected for ethanol-based protocols or long-term storage of prepared solutions.
-
Nelfinavir Mesylate for HIV and Ferroptosis
2026-09-22
Nelfinavir Mesylate is a high-potency HIV-1 protease inhibitor that also provides a practical chemical entry point into DDI2–NFE2L1 and ferroptosis research. This guide connects antiviral assay design with cell-stress workflows, emphasizing solution handling, controls, quantitative readouts, and troubleshooting.
-
Otilonium Bromide Experimental Workflows
2026-09-22
Otilonium Bromide is a high-purity antimuscarinic agent for controlled studies of cholinergic signaling, smooth-muscle contractility, and receptor-mediated physiology. This workflow-focused guide shows how to build reproducible concentration screens, select practical assay controls, and translate structure-based screening lessons into stronger validation strategies without overstating antiviral relevance.
-
Azilsartan in Reliable Cell Assays
2026-09-21
This scenario-based guide explains how Azilsartan (TAK-536, SKU B2210) can improve interpretation of viability, proliferation, and inflammation assays by providing selective AT1 receptor pharmacology. It covers solvent compatibility, concentration planning, controls, data interpretation, and practical supplier-selection criteria.
-
D-N-Acetylgalactosamine Protocol Guide
2026-09-21
D-N-Acetylgalactosamine provides a defined, water-soluble reagent for glycoprotein constituent measurements and brain heteropolysaccharides analysis. It is appropriate for freshly prepared aqueous or compatible DMSO workflows, but not for ethanol-based protocols or long-term storage of prepared solutions.
-
Cell Counting Kit-8 (CCK-8) Plus: Practical Guide
2026-09-20
Cell Counting Kit-8 Plus (SKU K2268) provides a water-soluble WST-8 readout for estimating viable-cell signal in proliferation, cytotoxicity, and drug-response experiments. It is appropriate as a controlled metabolic endpoint, but should not be treated as a direct cell count or stand-alone proof of a death mechanism, compound selectivity, or target-specific drug action.
-
Chenodeoxycholic Acid: Mechanism Beyond FXR
2026-09-19
Chenodeoxycholic Acid (CDCA) is more than a bile acid ligand: it can serve as a mechanistic probe linking FXR activation to transcriptional and inflammatory outcomes. This article explains how to design interpretation-focused experiments using CDCA, including insights from the FXR–KLF11 pathway in contrast-induced acute kidney injury.
-
Hierarchical Mitochondrial Repair in Diabetic Periodontitis
2026-09-18
The reference study develops a macrophage-targeted, ROS-responsive nanoparticle–hydrogel platform that delivers MitoQ to dysfunctional mitochondria in M1 macrophages. By combining selective cellular uptake, mitochondrial repair, ROS-triggered release, and local periodontal retention, the system reduced inflammatory signaling and improved alveolar bone regeneration in a diabetic periodontitis model.
-
ATM Inhibition Drives Metabolic Adaptation
2026-09-18
Huang et al. show that suppressing ATM promotes macropinocytosis, allowing cancer cells to acquire extracellular nutrients and survive under nutrient-poor conditions. The study identifies branched-chain amino acid dependence as a metabolic vulnerability created by ATM inhibition and supports combined targeting of ATM signaling and macropinocytosis.
-
TUNEL Assay: From DNA Damage to Translation
2026-09-17
A translational framework for using TUNEL-based DNA fragmentation analysis to connect apoptosis biology with vascular repair, blood-spinal cord barrier integrity, and therapeutic decision-making after spinal cord injury.
-
Lysosomal β-Galactosidase Staining Kit for Senescence
2026-09-17
Use X-gal chromogenic staining to visualize lysosomal acidic β-galactosidase in cultured cells and tissue sections while keeping senescence interpretation appropriately controlled. This guide connects practical cell senescence staining with cisplatin-resistance research, emphasizing workflow reproducibility, consumable compatibility, and the limits of β-galactosidase as a standalone biomarker.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-16
This guide explains how to use the Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, for practical HMGB1 detection in Western blot, immunohistochemistry, and flow cytometry workflows. It is a research-use reagent supported by product dossier information, not a diagnostic, therapeutic, or clinically validated assay component, and no directly matched paper evidence is assumed.